former med student for equity research questions about pre-hire assignment

>How strong is the phase1/2 data?
>Compare the pivotal with the previous trial design. What has been changed? Identify those >risk factors? 
>Any similar trials? Or other trials use a similar endpoint? How difficult to achieve clinical >significance for the endpoint? Will it take longer than the period of the trial? Patient >variability?…etc

>of course you can discuss mechanism of action too.

>They may ask you if positive, how much the data can move the stock price? But the answer really doesn't matter…

I have an assignment due tomorrow in which I have to state whether three pending trials will read out positively or negatively.

The pre-clinical data is statistically significant against placebo and I have laid it out but that is not compelling enough.

I want to make something of the fact that now the sample size in placebo controlled crossover trials will be reduced from 500 to say 100 or 30 and may be viewed with skepticism.

How do I develop this thesis?

1 Comments
 

Molestiae ut ab aperiam qui recusandae adipisci laudantium. Blanditiis et quasi iure nihil. Quidem hic consectetur eum non voluptas atque.

Consequuntur dolor cupiditate laudantium officiis et animi sequi. Nam nemo unde voluptates aut eaque nisi eos expedita. Iure voluptatum eos consequuntur saepe dolores et at mollitia. Facilis doloremque minus dolorem consequuntur excepturi magnam corrupti. Atque harum quis ea animi cum accusantium sunt.

Aut rerum debitis aut iste temporibus ea magnam. Ipsum debitis sint praesentium enim. Nobis in veritatis illo voluptates iste vero.

Impedit atque neque veritatis ut. Cumque dolore et cupiditate id ut sint qui. Voluptatem quo eum assumenda nihil veritatis. Nisi debitis omnis officia temporibus et ipsa. Nihil doloremque nemo laborum a enim repudiandae.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.8%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
CompBanker's picture
CompBanker
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”